Ming-Kuei Jang
Vorstandsvorsitzender bei Aprinoia Therapeutics, Inc.
Profil
Ming-Kuei Jang is the founder of Aprinoia Therapeutics, Inc. (founded in 2015) where he holds the title of Chief Executive Officer.
He is also the founder of Aprinoia Therapeutics, Inc. (founded in 2015) where he holds the title of Chairman & President-Asia Operations.
Currently, Dr. Jang is the Chief Scientific Officer at APRINOIA Therapeutics LLC.
In the past, he worked as an Associate Director at Glaxosmithkline China Ltd.
from 2010 to 2012.
Dr. Jang completed his undergraduate studies at National Taiwan University and obtained a doctorate degree from Boston University School of Medicine.
Aktive Positionen von Ming-Kuei Jang
| Unternehmen | Position | Beginn |
|---|---|---|
Aprinoia Therapeutics, Inc.
 Aprinoia Therapeutics, Inc. BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a drug discovery and early development company. The company was founded by Ming-Kuei Jang in May 20, 2015 and is headquartered in Taipei, Taiwan. | Vorstandsvorsitzender | 20.05.2015 |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Gründer | 01.01.2015 |
| APRINOIA Therapeutics LLC | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Ming-Kuei Jang
| Unternehmen | Position | Ende |
|---|---|---|
| Glaxosmithkline China Ltd. | Corporate Officer/Principal | 01.03.2012 |
Ausbildung von Ming-Kuei Jang
| National Taiwan University | Undergraduate Degree |
| Boston University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
 | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Glaxosmithkline China Ltd. | |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Health Technology |
| APRINOIA Therapeutics LLC |
